Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 23575393)

1.

An individualized conditional survival calculator for patients with rectal cancer.

Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ.

Dis Colon Rectum. 2013 May;56(5):551-9. doi: 10.1097/DCR.0b013e31827bd287.

2.

Practical application of a calculator for conditional survival in colon cancer.

Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA.

J Clin Oncol. 2009 Dec 10;27(35):5938-43. doi: 10.1200/JCO.2009.23.1860. Epub 2009 Oct 5.

3.

An interactive tool for individualized estimation of conditional survival in rectal cancer.

Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR Jr.

Ann Surg Oncol. 2011 Jun;18(6):1547-52. doi: 10.1245/s10434-010-1512-3. Epub 2011 Jan 5.

4.

Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer.

Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ.

Arch Surg. 2012 Jun;147(6):513-9. doi: 10.1001/archsurg.2011.2281.

5.

Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.

Bhangu A, Kiran RP, Audisio R, Tekkis P.

Eur J Surg Oncol. 2014 Nov;40(11):1510-6. doi: 10.1016/j.ejso.2014.02.239. Epub 2014 Feb 28.

PMID:
24704032
6.
7.

Surgeon-related factors and outcome in rectal cancer.

Porter GA, Soskolne CL, Yakimets WW, Newman SC.

Ann Surg. 1998 Feb;227(2):157-67.

8.

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer.

van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T, Hospers GA, Havenga K.

Ann Oncol. 2013 Jul;24(7):1762-9. doi: 10.1093/annonc/mdt124. Epub 2013 Mar 22.

9.

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

Velenik V, Oblak I, Anderluh F.

Radiat Oncol. 2010 Sep 29;5:88. doi: 10.1186/1748-717X-5-88.

10.

Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.

Cho MM, Morgan JW, Knutsen R, Oda K, Shavlik D, Knutsen S, Kazanjian K.

Dis Colon Rectum. 2013 Dec;56(12):1357-65. doi: 10.1097/01.dcr.0000436362.81611.de.

PMID:
24201389
11.

Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.

Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.

Colorectal Dis. 2008 Jul;10(6):563-8. Epub 2007 Dec 7.

PMID:
18070184
12.

The impact of T and N stage on long-term survival of rectal cancer patients in the community.

Kozak KR, Moody JS.

J Surg Oncol. 2008 Sep 1;98(3):161-6. doi: 10.1002/jso.21107.

PMID:
18615481
13.

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.

Dis Colon Rectum. 2004 Nov;47(11):1798-807.

PMID:
15622571
14.

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.

Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.

Dis Colon Rectum. 2004 Dec;47(12):2025-31.

PMID:
15657650
15.

Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.

Huebner M, Wolff BG, Smyrk TC, Aakre J, Larson DW.

World J Surg. 2012 Mar;36(3):675-83. doi: 10.1007/s00268-011-1409-8.

PMID:
22270980
16.

Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.

Zhan T, Gu J, Li M, Du C.

Dis Colon Rectum. 2013 Apr;56(4):422-32. doi: 10.1097/DCR.0b013e31828576c6.

PMID:
23478609
17.

Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.

Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB.

Am Surg. 2013 Feb;79(2):151-61.

PMID:
23336654
18.

Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.

Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN.

Cancer. 2010 May 1;116(9):2234-41. doi: 10.1002/cncr.24966.

19.

A novel data-driven prognostic model for staging of colorectal cancer.

Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH.

J Am Coll Surg. 2011 Nov;213(5):579-588, 588.e1-2. doi: 10.1016/j.jamcollsurg.2011.08.006. Epub 2011 Sep 16.

PMID:
21925905
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk